{
    "initial_scores": {
        "ideological_tilt": 1,
        "immigration": 0,
        "executive_power": 2,
        "federalism": 0,
        "security_liberty": 0,
        "economic_regulation": 3,
        "social_inclusion": 0
    },
    "critique": "The document is an executive order addressing drug shortages. It aims to prevent and reduce disruptions in the supply of life-saving medicines by directing the FDA to broaden reporting of manufacturing discontinuances, expedite regulatory reviews, and review certain behaviors by market participants. The order reflects a moderate level of government intervention in the pharmaceutical market to address a public health issue.",
    "revised_scores": {
        "ideological_tilt": 1,
        "immigration": 0,
        "executive_power": 2,
        "federalism": 0,
        "security_liberty": 0,
        "economic_regulation": 3,
        "social_inclusion": 0
    }
}